drugset / Trial / NCT03274102

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

NCT03274102

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety and immunogenicity of concomitant administration of EV71 vaccine with recombinant hepatitis B vaccine/Group A meningococcal polysaccharide vaccine.

Timeline

Start
2017-04-22
Primary completion
2017-11-01
Completion
2017-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject EV71 vaccine Vaccine 0.5 ml Intramuscular
Subject Group A meningococcal polysaccharide vaccine Vaccine 150 ug Subcutaneous
Subject recombinant hepatitis B vaccine Vaccine 0.5 ml Intramuscular